Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
21.61
+0.20 (0.91%)
Oct 21, 2026, 12:00 PM EDT - Market open
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Fresenius Medical Care AG stock has a consensus rating of "Hold" and an average price target of $23.92. The average 1-year stock price forecast is 10.72% higher than the current stock price, while the lowest is $17.36 (-19.65%) and the highest is $38.13 (+76.49%).
Price Target: $23.92 (+10.72%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Fresenius Medical Care AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 0 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 0 |
| Hold | 3 | 2 | 2 | 2 | 3 | 3 |
| Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | +11.09% | Oct 12, 2026 |
| Bernstein | Bernstein | Hold Maintains $26 → $26 | Hold | Maintains | $26 → $26 | +19.42% | Aug 6, 2026 |
| Exane BNP Paribas | Exane BNP Paribas | Sell Downgrades $20 | Sell | Downgrades | $20 | -7.89% | Jul 28, 2026 |
Financial Forecast
Revenue This Year
19.46B
from 19.63B
Decreased by -0.84%
Revenue Next Year
20.10B
from 19.46B
Increased by 3.27%
EPS This Year
4.07
from 4.28
Decreased by -4.95%
EPS Next Year
4.25
from 4.07
Increased by 4.43%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.